|
| Agent | Dose | Route | Comments |
|
| Preadjuvant phase of therapy (every 3 weeks 4 cycles) |
|
| Vincristine | 1.5 mg/m2 |
iv over 2–15 minutes | Max dose 2 mg; day 1 only |
| Etoposide | 150 mg/m2 |
iv over 1 hour | Day 1 only |
| Dexrazoxane | 750 mg/m2 |
iv over 15 minutes | Just before doxorubicin |
| Doxorubicin |
75 mg/m2 |
iv over 15 minutes | Day 1 only |
| Ifosfamide | 3 g/m2 |
iv daily 3 | Continuous infusion. Mix |
| + MESNA | 3 g/m2 |
iv daily 4 | with MESNA in 240–360 mL NS days 1, 2, 3. |
| MESNA only day 4 (portable pump as outpatient) |
|
| CHPP phase |
|
| Cisplatin | 100 mg/m2 | Intraperitoneal | As continuous peritoneal perfusion at 42°C 1.5 hr |
|
| Radio sensitization during RT |
|
| Temozolomide | 75 mg/m2 | po | Daily 5 2 weeks |
| Bevacizumab | 5 mg/kg | iv | q2 weeks 2 doses begin before RT |
|
| Pre-RT (2 cycles) and post-RT (10 cycles) |
|
| Temozolomide | 100 mg/m2 | po | Daily 5 each month |
| Irinotecan | 10 mg/m2 |
iv | Daily 5 2 weeks each month; may do as home infusions |
|
| Chronic continuation chemotherapy |
|
| Valproate | 500 mg/m2 | po | Daily; divide BID monitor level <100 |
| Rapamycin | 2 mg/m2 | po | Daily round to nearest mg |
| Cyclophosphamide | 25 mg | po | If >1.5 m2 may give 50 mg daily. Monitor cbc |
|